Related Experiment Video

Updated: Nov 12, 2025

High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model
08:16

High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model

Published on: March 16, 2022

3.8K

Acute Lower Limb Ischemia in Patients Infected with COVID-19

Nabil Al-Zoubi1, Nawaf Shatnawi1, Hamza Jarbo1

  • 1Department of General Surgery/Vascular Surgery, Jordan University of Science and Technology, Irbid, Jordan.

International Journal of General Medicine
|March 19, 2021
PubMed

Insights

COVID-19 patients had a 0.54% prevalence of acute lower limb ischemia (ALLI). Patients with COVID-19 pneumonia who developed ALLI during hospitalization experienced high mortality rates.

Area of Science:

  • Vascular Surgery
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • COVID-19 infection has been associated with various vascular complications.
  • Acute lower limb ischemia (ALLI) is a serious condition that can occur in critically ill patients.
  • Understanding the prevalence and outcomes of ALLI in COVID-19 patients is crucial for clinical management.

Purpose of the Study:

  • To determine the prevalence of acute lower limb ischemia (ALLI) in patients with COVID-19.
  • To analyze the characteristics of COVID-19 patients who develop ALLI.
  • To evaluate the outcomes of ALLI in this patient population.

Main Methods:

  • Retrospective review of patients admitted to King Abdullah University Hospital (KAUH) between November 1, 2020, and December 31, 2020.
  • Identification of patients diagnosed with both ALLI and COVID-19 infection.
  • Analysis of patient demographics, clinical presentation, treatment, and outcomes.

Main Results:

  • Seven out of 1300 COVID-19 patients (0.54%) were diagnosed with ALLI.
  • Male patients with COVID-19 pneumonia who developed ALLI during hospitalization had a high mortality rate (100% mortality within 24 hours).
  • Female patients presenting with ALLI and subsequently diagnosed with COVID-19 had better outcomes, with no deaths but one case of amputation.

Conclusions:

  • The prevalence of ALLI among hospitalized COVID-19 patients was found to be 0.54%.
  • COVID-19 patients with pneumonia who develop ALLI during their hospital stay face a significantly high risk of mortality.
  • Prompt diagnosis and management of ALLI in COVID-19 patients are critical, with outcomes potentially differing based on presentation and comorbidities.
Abstract

Keywords:
ALLICOVID-19KAUH

More Related Videos

Methods for Acute and Subacute Murine Hindlimb Ischemia07:57

Methods for Acute and Subacute Murine Hindlimb Ischemia

Published on: June 21, 2016

16.9K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.6K

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
150
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
121
Arteries of Lower Limbs01:20

Arteries of Lower Limbs

The external iliac artery transitions out of the body cavity, entering the femoral region of the lower leg, and is renamed the femoral artery at the point where it traverses the body wall. This artery is responsible for the distribution of blood to the thigh's deep muscles and the skin's ventral and lateral regions, achieved through several minor branches and the lateral deep femoral artery, which also spawns a lateral circumflex artery. The knee area receives blood from the genicular...
3.2K
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
116
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
130
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
62